Follow
Lidia Mateo
Lidia Mateo
PhD student at IRB Barcelona
Verified email at irbbarcelona.org
Title
Cited by
Cited by
Year
A transposable element insertion confers xenobiotic resistance in Drosophila
L Mateo, A Ullastres, J González
PLoS genetics 10 (8), e1004560, 2014
1052014
Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells
A Cañellas-Socias, C Cortina, X Hernando-Momblona, S Palomo-Ponce, ...
Nature 611 (7936), 603-613, 2022
632022
Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy
A Alvarez-Varela, L Novellasdemunt, FM Barriga, X Hernando-Momblona, ...
Nature Cancer 3 (9), 1052-1070, 2022
462022
Pogo-like Transposases Have Been Repeatedly Domesticated into CENP-B-Related Proteins
L Mateo, J Gonzalez
Genome biology and evolution 6 (8), 2008-2016, 2014
462014
A community challenge for a pancancer drug mechanism of action inference from perturbational profile data
EF Douglass, RJ Allaway, B Szalai, W Wang, T Tian, A Fernández-Torras, ...
Cell Reports Medicine 3 (1), 2022
392022
Genome-wide patterns of local adaptation in Western European Drosophila melanogaster natural populations
L Mateo, GE Rech, J González
Scientific Reports 8 (1), 16143, 2018
202018
Drug repositioning beyond the low-hanging fruits
M Duran-Frigola, L Mateo, P Aloy
Current Opinion in Systems Biology 3, 95-102, 2017
152017
Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns
L Mateo, M Duran-Frigola, A Gris-Oliver, M Palafox, M Scaltriti, P Razavi, ...
Genome Medicine 12, 1-23, 2020
142020
Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype
M Maus, V López-Polo, L Mateo, M Lafarga, M Aguilera, E De Lama, ...
Nature Metabolism 5 (12), 2111-2130, 2023
122023
Identification and drug-induced reversion of molecular signatures of Alzheimer’s disease onset and progression in AppNL-G-F, AppNL-F, and 3xTg-AD mouse …
E Pauls, S Bayod, L Mateo, V Alcalde, T Juan-Blanco, M Sánchez-Soto, ...
Genome Medicine 13, 1-23, 2021
122021
Exploring the OncoGenomic Landscape of cancer
L Mateo, O Guitart-Pla, M Duran-Frigola, P Aloy
Genome Medicine 10, 1-8, 2018
92018
A PanorOmic view of personal cancer genomes
L Mateo, O Guitart-Pla, C Pons, M Duran-Frigola, R Mosca, P Aloy
Nucleic Acids Research 45 (W1), W195-W200, 2017
72017
The efficacy of chemotherapy is limited by intratumoural senescent cells that persist through the upregulation of PD-L2
S Chaib, JA López-Domínguez, M Lalinde, N Prats, I Marin, K Meyer, ...
bioRxiv, 2022.11. 04.501681, 2022
52022
Bioactivity profile similarities to expand the repertoire of COVID-19 drugs
M Duran-Frigola, M Bertoni, R Blanco, V Martínez, E Pauls, V Alcalde, ...
Journal of Chemical Information and Modeling 60 (12), 5730-5734, 2020
52020
Genome-wide patterns of local adaptation in Drosophila melanogaster: adding intra European variability to the map
L Mateo, GE Rech, J González
bioRxiv, 269332, 2018
42018
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2
S Chaib, JA López-Domínguez, M Lalinde-Gutiérrez, N Prats, I Marin, ...
Nature Cancer, 1-15, 2024
22024
Abstract C040: Investigating oncogene-inflammation cooperativity in pancreatic cancer
K Woess, SB Araguás, A Diéguez, L Mateo, DA Curbelo
Cancer Research 84 (2_Supplement), C040-C040, 2024
2024
Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells
E Batlle, A Caņellas Socias, C Cortina, X Hernando Momblona, ...
Nature, 2022, vol. 611, p. 603–613, 2022
2022
Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns
JV Arribas Lopez, M Bellet Ezquerra, P Aloy, L Mateo, V Serra Elizalde
Genome Medicine, 2020, vol. 12, núm. 1, p. 78, 2020
2020
Bioactivity Profile Similarities to Expand the Repertoire of COVID-19 Drugs
DF Miquel, B Martino, P Eduardo, A Victor, T Gemma, V Nuria, FT Adria, ...
2020
The system can't perform the operation now. Try again later.
Articles 1–20